Related Experiment Video

Updated: Jul 16, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K

Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer

Lujing Li1, Renjie Li1, Jiachun Li2

  • 1Department of Ultrasound, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.

Journal of Materials Science. Materials in Medicine
|September 22, 2023
PubMed

Insights

New nanoparticles show promise for prostate cancer chemotherapy. These drug-loaded nanoparticles are designed to release medication effectively within the tumor environment, improving treatment and reducing side effects.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Traditional chemotherapy for prostate cancer faces challenges including poor selectivity, low bioavailability, and systemic side effects.
  • Stimuli-responsive drug delivery systems leverage tumor microenvironment characteristics for targeted chemotherapy.
  • Developing advanced drug carriers is crucial for improving prostate cancer treatment efficacy.

Purpose of the Study:

  • To design and synthesize novel glutathione (GSH)-sensitive poly-Tetraethylene glycol nanoparticles loaded with docetaxel (DTX) for prostate cancer chemotherapy.
  • To evaluate the physicochemical properties, in vitro biocompatibility, and anti-tumor efficacy of the developed nanoparticles.
  • To explore the potential of these nanoparticles as a targeted therapeutic strategy for prostate cancer.

Main Methods:

  • Synthesis and characterization of DTX-loaded poly-Tetraethylene glycol nanoparticles (poly-TTG-SS@DTX NPs) with specific size and surface charge.
  • In vitro assessment of nanoparticle compatibility with healthy cells at varying concentrations.
  • Evaluation of the anti-tumor effect of poly-TTG-SS@DTX NPs on C4-2 prostate cancer cells compared to free drug and blank carriers.

Main Results:

  • Poly-TTG-SS@DTX NPs exhibited a nanosized diameter (92.8 ± 2.5 nm) and a negative surface charge (-24.7 ± 5.56 mV).
  • Nanoparticles demonstrated excellent biocompatibility with healthy cells, with cellular activity remaining over 90% at 100 µg/mL.
  • The drug-loaded nanoparticles showed a significantly stronger cancer cell-killing effect (25.21%) compared to free docetaxel (19.93%) and blank carriers (20.96%).

Conclusions:

  • GSH-sensitive poly-TTG-SS@DTX NPs offer a promising platform for targeted prostate cancer chemotherapy.
  • The nanoparticles facilitate rapid and sustained drug release in the tumor microenvironment, enhancing anti-tumor activity.
  • This novel drug delivery system represents a potential advancement in improving the therapeutic strategy for prostate cancer treatment.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.2K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551